DANIELLE DAVIS: Open Payments
NPI 1679180111 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,559 in 181 payments from 14 companies in 2025. Trend: 2023 $1,556 · 2024 $2,167 · 2025 $2,559
Food & beverage: $2,559
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 31 | $429 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 29 | $343 |
| Lundbeck LLC | 23 | $316 |
| E.R. Squibb & Sons, L.L.C. | 11 | $278 |
| Otsuka America Pharmaceutical, Inc. | 11 | $223 |
| Teva Pharmaceuticals USA, Inc. | 20 | $223 |
| Alkermes, Inc. | 17 | $216 |
| Neurocrine BioSciences, Inc. | 11 | $175 |
| ABBVIE INC. | 18 | $168 |
| Vanda Pharmaceuticals Inc. | 5 | $105 |
Products named: INVEGA SUSTENNA, CAPLYTA, COBENFY, ABILIFY MAINTENA, ARISTADA, INGREZZA, VRAYLAR, REXULTI.
Industry payments across OH — which companies pay providers there.
